MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 68 filers reported holding MONTE ROSA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59 | -28.9% | 12,225 | +0.6% | 0.00% | – |
| Q2 2023 | $83 | -12.6% | 12,150 | -0.3% | 0.00% | – |
| Q1 2023 | $95 | -38.7% | 12,183 | -40.1% | 0.00% | – |
| Q4 2022 | $155 | -99.9% | 20,348 | -0.0% | 0.00% | – |
| Q3 2022 | $166,000 | -15.3% | 20,357 | +0.3% | 0.00% | – |
| Q2 2022 | $196,000 | -15.9% | 20,298 | +22.1% | 0.00% | – |
| Q1 2022 | $233,000 | +65.2% | 16,621 | +141.0% | 0.00% | – |
| Q4 2021 | $141,000 | +54.9% | 6,896 | +68.2% | 0.00% | – |
| Q3 2021 | $91,000 | – | 4,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $12,029,000 | 7.99% |
| NEA Management Company, LLC | 7,703,205 | $62,935,000 | 3.14% |
| Cormorant Asset Management, LP | 2,993,717 | $24,459,000 | 1.71% |
| Alphabet Inc. | 1,464,015 | $11,961,000 | 0.61% |
| Avoro Capital Advisors LLC | 3,363,333 | $27,478,000 | 0.51% |
| Casdin Capital, LLC | 510,882 | $4,174,000 | 0.27% |
| RTW INVESTMENTS, LP | 1,214,572 | $9,923,000 | 0.23% |
| Woodline Partners LP | 502,411 | $4,105,000 | 0.06% |
| Virtus Investment Advisers, Inc. | 12,638 | $103,000 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $230,000 | 0.04% |